Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.15.6353

Risk Factors of Lymph Node Metastases with Endometrial Carcinoma  

Cetinkaya, Kadir (Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital)
Atalay, Funda (Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital)
Bacinoglu, Ahmet (Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.15, 2014 , pp. 6353-6356 More about this Journal
Abstract
Background: The purpose of this study was to investigate and evaluate risk factors for lymph node metastases (LNM) in cases of endometrial cancer (EC). Materials and Methods: A retrospective single institution analysis of patients surgically staged for EC at Ankara Oncology Education and Research Hospital from 1996 to 2010 was performed. Roles of prognostic factors, such as age, histological type, grade, depth of myometrial invasion, cervical involvement, peritoneal cytology, and tumor size, in the prediction of LNM were evaluated. Fisher's exact test and logistic regression analysis were used to assess the effects of various factors on LNM. Results: LNM was observed in 22 out of 247 patients (8.9%) and was significantly more common in the presence of tumors of higher grade, deep myometrial invasion (DMI), cervical involvement, size >2cm, and with positive peritoneal cytology. Logistic regression analysis revealed that DMI remained the only independent risk factor for LNM. NPV, PPV, sensitivity, and specificity for satisfying LNM risk were 98.0, 19.5, 86.3, and 65.3%, respectively for DMI. Conclusions: The incidence of LNM is influenced independently by DMI. If data support a conclusion of DMI, LND should be seriously considered.
Keywords
Endometrial carcinoma; risk factors; myometrial invasion; lymph node; metastasis;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Abu-Rustum NR (2014). Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center. J Obstet Gynaecol Res, 40, 327-34.   DOI
2 Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group. Asian Pac J Cancer Prev, 15, 195-8.   과학기술학회마을   DOI   ScienceOn
3 Arango HA, Hoffman MS, Roberts WS, et al (2000). Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol, 95, 553-6.   DOI   ScienceOn
4 Atalay F, Cetinkaya K, Bacinoglu A (2013). Is the 2009 FIGO staging system really valuable for stage I endometrial cancer? Eur J Gynaecol Oncol, 34, 556-8.
5 Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 100, 1707-16.   DOI   ScienceOn
6 Ben-Shachar I, Pavelka J, Cohn DE, et al (2005). Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol, 105, 487-93.   DOI   ScienceOn
7 Binesh F, Akhavan A, Behniafard N, Jalilian S (2014). Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran. Asian Pac J Cancer Prev, 15, 2797-801.   과학기술학회마을   DOI   ScienceOn
8 Case AS, Rocconi RP, Straughn JM Jr, et al (2006). A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol, 108, 1375-9.   DOI   ScienceOn
9 Chan JK, Kapp DS (2007). Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol, 8, 831-41.   DOI   ScienceOn
10 Chi DS, Barakat RR, Palayekar MJ, et al (2008). The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer, 18, 269-73.   DOI   ScienceOn
11 Cragun JM, Havrilesky LJ, Calingaert B, et al (2005). Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol, 23, 3668-75.   DOI   ScienceOn
12 Creasman WT, Morrow CP, Bundy BN, et al (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-41.   DOI
13 Creasman W (2009). Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet, 105, 109.   DOI   ScienceOn
14 Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al (2012). Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol, 120, 1419-27.
15 Gallego JC, Porta A, Pardo MC, Fernandez C (2014). Evaluation of myometrial invasion in endometrial cancer: comparison of diffusion-weighted magnetic resonance and intraoperative frozen sections. Abdom Imaging. Apr 4. [Epub ahead of print].
16 Girardi F, Petru E, Heydarfadai M, Haas J, Winter R (1993). Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol, 49, 177-80.   DOI   ScienceOn
17 Neubauer NL, Lurain JR (2011). The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol, 2011, 814649.
18 Goudge C, Bernhard S, Cloven NG, Morris P (2004). The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol, 93, 536-9.   DOI
19 Hahn HS, Song HS, Lee IH, et al (2013). Magnetic resonance imaging and intraoperative frozen sectioning for the evaluation of risk factors associated with lymph node metastasis in endometrial cancer. Int J Gynecol Cancer, 23, 1411-6.   DOI
20 Mariani A, Webb MJ, Keeney GL, et al (2000). Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gyneco, 182, 1506-19.   DOI   ScienceOn
21 Park JY, Kim EN, Kim DY, et al (2008). Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol, 108, 486-92.   DOI   ScienceOn
22 Todo Y, Sakuragi N (2013). Methodological considerations in the analysis of the therapeutic significance of lymphadenectomy in endometrial cancer. Taiwan J Obstet Gynecol, 52, 8-13.   DOI
23 Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90.   과학기술학회마을   DOI   ScienceOn
24 Zuurendonk LD, Smit RA, Mol BW, et al (2006). Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol, 32, 450-4.   DOI
25 Kang S, Todo Y, Watari H (2014). Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients? J Obstet Gynaecol Res, 40, 322-6.   DOI